• Mashup Score: 0

    EPFL researchers have published a method for 3D-printing an ink that contains calcium carbonate-producing bacteria. The 3D-printed mineralized bio-composite is unprecedently strong, light, and environmentally friendly, with a range of applications from art to biomedicine.

    Tweet Tweets with this article
    • #3D printing with #bacteria-loaded ink produces bone-like composites @EPFL_en #mechanicalproperties #printing #materialsprocessing https://t.co/ILVcwjHOuz

  • Mashup Score: 7
    NextMed Health - 1 year(s) ago

    NextMed Health is an innovation platform catalyzing the future of health and medicine. From the founder and team behind Exponential Medicine, NextMed brings together the global ecosystem of technology & healthcare innovators through summits, community & collaboration at the convergence of A

    Tweet Tweets with this article
    • RT @daniel_kraft: Being #3D scanned @bluevishnux @alexxhenry into a 3D Avatar Excited to have BlueVishnu at https://t.co/6uo9JkRP35, whe…

  • Mashup Score: 4

    A research partnership between Tulane and Rice universities has resulted in a newly developed synthetic skin being used to study mosquito feeding habits and eliminate the need for human or animal testing. The gelatin-like skin can be 3D-printed and artificial intelligence is used to identify behavioral patterns.

    Tweet Tweets with this article
    • The #3D-printed skin may help researchers study how #mosquitoes transmit deadly #diseases and eliminate the need for human and animal testing @Tulane #tropicaldiseases #animalresearch https://t.co/j34eJS0Av1

  • Mashup Score: 0
    NextMed Health - 1 year(s) ago

    NextMed Health is an innovation platform catalyzing the future of health and medicine. From the founder and team behind Exponential Medicine, NextMed brings together the global ecosystem of technology & healthcare innovators through summits, community & collaboration at the convergence of A

    Tweet Tweets with this article
    • Being #3D scanned @bluevishnux @alexxhenry into a 3D Avatar Excited to have BlueVishnu at https://t.co/6uo9JkRP35, where every participant will have the opportunity to be scanned, & digitally reconstructed See https://t.co/qK6fVSbKbx #metaverse #digitalhealth #Avatar https://t.co/SBcBAwEmZ4

  • Mashup Score: 30

    Stochastic processes, such as genetic instability and microenvironment evolution, drive tumor heterogeneity, thereby creating the chaotic appearance of tumors in histopathology. In this issue of Cell, Lin et al. reveal that tumors are surprisingly spatially organized from a molecular to tissue scale, indicating that cancers evolve as autonomously patterned systems.

    Tweet Tweets with this article
    • "Coordinated cancer chaos," an oxymoron? What we've learned from spatial genomics, #3D reconstruction, and #AI is that cancer tissue is surprisingly spatially organized and patterned https://t.co/oGzu8J8osu @CellCellPress @vanRheenen_Lab based on paper below https://t.co/OLhkwp2a8y

  • Mashup Score: 0

    Scientists used patient stem cells and 3D bioprinting to produce eye tissue that will advance understanding of the mechanisms of blinding diseases. The research team from the National Eye Institute (NEI), part of the National Institutes of Health, printed a combination of cells that form the outer blood-retina barrier—eye tissue that supports the retina’s light-sensing photoreceptors. The…

    Tweet Tweets with this article
    • Researchers use #3D bioprinting to create eye tissue @NatEyeInstitute #visiondisorders #eyediseases #stemcellresearch https://t.co/Azu9uHJlnk

  • Mashup Score: 1

    The latest major breakthrough in cancer is a drug called capivasertib, which has shown ‘remarkable’ results against advanced breast cancer in its first phase III trial. Results released at the prestigious San Antonio Breast Cancer Symposium (SABCS) show that the drug can double the time before cancer returns. But what is capivasertib? How does it work – and how was it discovered? Here at The…

    Tweet Tweets with this article
    • We're proud of the major role we played in the discovery and development of the AKT inhibitor, capivasertib. Professor David Barford's team carried out the fundamental research to reveal AKT's #3D structure (below) and how it is activated. Read more: https://t.co/EeDB0w7kXc https://t.co/SlZaFbxlOH